Find trials
Consejos para buscar

Pharmacogenomics and the Potential for Utilization of Testing Results for Patient Care in the Cardiac Surgical Intensive Care Unit

Overview

Información sobre este estudio

The overall goals of this pilot study are to: (1) describe pharmacogenomics (PGx) testing results and identify PGx variants that may inform treatment regimens and symptom management in cardiac surgical patients with an ICU stay, and (2) describe cardiac critical care team members’ awareness and attitudes towards the applications of pharmacogenomics testing results for their practice before and after completion of a PGx education module.
 

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria

Adults scheduled for cardiovascular surgery with an anticipated ICU stay

  • Patient age ≥ 18
  • Mayo Clinic patient with a scheduled Cardiac surgery
  • Patient must provide own written informed consent and written HIPAA authorization prior to initiation of any study-related procedures

Cardiac critical care team members

  • Cardiac surgeons
  • RN caring for patients in the cardiac surgical intensive care unit
  • Pharmacists caring for patients in the cardiac surgical intensive care unit
  • NPs and PAs caring for patients in the cardiac surgical intensive care unit
  • Intensivists caring for patients in the cardiac surgical intensive care unit

Exclusion Criteria: 

Adults scheduled for cardiovascular surgery with an anticipated ICU stay

  • Patient age < 18
  • Scheduled ventricular assist device (VAD) implantation
  • Known pregnancy
  • Patient with uncontrolled concurrent illness including documented psychiatric illness, or situations that would limit compliance with the study requirements or the ability to willingly provide informed consent (i.e., documented dementia)
  • Surgery occurring less than 24 hours from potential consent time (to allow for PGx test turnaround time of 24 hours)

Cardiac critical care team members

  • Providers not caring for patients having cardiac surgery with a stay in the cardiac surgical intensive care unit

 

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus

Rochester, Minn.

Investigador principal de Mayo Clinic

Linda Chlan, Ph.D., R.N.

Cerrado para la inscripción

More information

Publicaciones

Publications are currently not available

Otros temas en investigación

.
CLS-20418901

Mayo Clinic Footer